vs

Side-by-side financial comparison of RAPID MICRO BIOSYSTEMS, INC. (RPID) and USCB FINANCIAL HOLDINGS, INC. (USCB). Click either name above to swap in a different company.

USCB FINANCIAL HOLDINGS, INC. is the larger business by last-quarter revenue ($22.2M vs $11.3M, roughly 2.0× RAPID MICRO BIOSYSTEMS, INC.). USCB FINANCIAL HOLDINGS, INC. runs the higher net margin — 6.1% vs -110.8%, a 116.9% gap on every dollar of revenue. On growth, RAPID MICRO BIOSYSTEMS, INC. posted the faster year-over-year revenue change (37.3% vs 14.7%). USCB FINANCIAL HOLDINGS, INC. produced more free cash flow last quarter ($42.5M vs $-3.3M). Over the past eight quarters, RAPID MICRO BIOSYSTEMS, INC.'s revenue compounded faster (41.8% CAGR vs 12.3%).

Rapid Micro Biosystems, Inc. develops and manufactures automated microbial detection and quality control solutions for the life sciences industry. Its core products serve biopharmaceutical manufacturers, contract development and manufacturing organizations, operating across key global markets including North America, Europe and Asia-Pacific, helping clients cut testing timelines and improve operational efficiency.

USCB Financial Holdings, Inc. is a U.S.-headquartered bank holding company that offers comprehensive retail and commercial banking services, including deposit products, personal and business loans, wealth management, and digital banking tools. It primarily serves individual consumers, small and medium-sized enterprises, and local corporate clients across its operating regions in the United States, prioritizing personalized customer experiences and community-oriented financial services.

RPID vs USCB — Head-to-Head

Bigger by revenue
USCB
USCB
2.0× larger
USCB
$22.2M
$11.3M
RPID
Growing faster (revenue YoY)
RPID
RPID
+22.6% gap
RPID
37.3%
14.7%
USCB
Higher net margin
USCB
USCB
116.9% more per $
USCB
6.1%
-110.8%
RPID
More free cash flow
USCB
USCB
$45.8M more FCF
USCB
$42.5M
$-3.3M
RPID
Faster 2-yr revenue CAGR
RPID
RPID
Annualised
RPID
41.8%
12.3%
USCB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
RPID
RPID
USCB
USCB
Revenue
$11.3M
$22.2M
Net Profit
$-12.5M
$1.4M
Gross Margin
Operating Margin
-108.2%
14.7%
Net Margin
-110.8%
6.1%
Revenue YoY
37.3%
14.7%
Net Profit YoY
-29.3%
-80.3%
EPS (diluted)
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RPID
RPID
USCB
USCB
Q4 25
$11.3M
$22.2M
Q3 25
$7.8M
$25.0M
Q2 25
$7.3M
$24.4M
Q1 25
$7.2M
$22.8M
Q4 24
$8.2M
$23.0M
Q3 24
$7.6M
$21.5M
Q2 24
$6.6M
$20.5M
Q1 24
$5.6M
$17.6M
Net Profit
RPID
RPID
USCB
USCB
Q4 25
$-12.5M
$1.4M
Q3 25
$-11.5M
$8.9M
Q2 25
$-11.9M
$8.1M
Q1 25
$-11.3M
$7.7M
Q4 24
$-9.7M
$6.9M
Q3 24
$-11.3M
$6.9M
Q2 24
$-12.6M
$6.2M
Q1 24
$-13.3M
$4.6M
Operating Margin
RPID
RPID
USCB
USCB
Q4 25
-108.2%
14.7%
Q3 25
-145.1%
47.3%
Q2 25
-167.3%
44.0%
Q1 25
-161.8%
44.2%
Q4 24
-124.5%
39.6%
Q3 24
-158.3%
42.5%
Q2 24
-202.1%
39.8%
Q1 24
-254.4%
34.3%
Net Margin
RPID
RPID
USCB
USCB
Q4 25
-110.8%
6.1%
Q3 25
-146.8%
35.8%
Q2 25
-163.3%
33.4%
Q1 25
-156.3%
33.5%
Q4 24
-117.6%
30.0%
Q3 24
-148.9%
32.3%
Q2 24
-190.1%
30.3%
Q1 24
-237.4%
26.2%
EPS (diluted)
RPID
RPID
USCB
USCB
Q4 25
$-0.26
Q3 25
$-0.26
$0.45
Q2 25
$-0.27
Q1 25
$-0.26
Q4 24
$-0.22
Q3 24
$-0.26
$0.35
Q2 24
$-0.29
Q1 24
$-0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RPID
RPID
USCB
USCB
Cash + ST InvestmentsLiquidity on hand
$20.0M
$38.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$33.2M
$217.2M
Total Assets
$74.9M
$2.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RPID
RPID
USCB
USCB
Q4 25
$20.0M
$38.5M
Q3 25
$18.9M
$56.8M
Q2 25
$18.3M
$54.8M
Q1 25
$18.9M
$98.0M
Q4 24
$16.9M
$77.0M
Q3 24
$22.0M
$38.5M
Q2 24
$37.1M
$77.3M
Q1 24
$22.4M
$126.5M
Stockholders' Equity
RPID
RPID
USCB
USCB
Q4 25
$33.2M
$217.2M
Q3 25
$44.3M
$209.1M
Q2 25
$54.5M
$231.6M
Q1 25
$65.5M
$225.1M
Q4 24
$75.4M
$215.4M
Q3 24
$84.4M
$213.9M
Q2 24
$94.6M
$201.0M
Q1 24
$105.9M
$195.0M
Total Assets
RPID
RPID
USCB
USCB
Q4 25
$74.9M
$2.8B
Q3 25
$84.4M
$2.8B
Q2 25
$75.6M
$2.7B
Q1 25
$85.4M
$2.7B
Q4 24
$98.2M
$2.6B
Q3 24
$105.8M
$2.5B
Q2 24
$117.1M
$2.5B
Q1 24
$127.7M
$2.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RPID
RPID
USCB
USCB
Operating Cash FlowLast quarter
$-3.2M
$42.8M
Free Cash FlowOCF − Capex
$-3.3M
$42.5M
FCF MarginFCF / Revenue
-29.6%
191.4%
Capex IntensityCapex / Revenue
0.8%
1.4%
Cash ConversionOCF / Net Profit
31.40×
TTM Free Cash FlowTrailing 4 quarters
$-31.9M
$95.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RPID
RPID
USCB
USCB
Q4 25
$-3.2M
$42.8M
Q3 25
$-9.1M
$20.1M
Q2 25
$-9.7M
$18.0M
Q1 25
$-9.1M
$14.6M
Q4 24
$-9.9M
$34.8M
Q3 24
$-8.6M
$11.3M
Q2 24
$-10.1M
$18.3M
Q1 24
$-15.5M
$8.1M
Free Cash Flow
RPID
RPID
USCB
USCB
Q4 25
$-3.3M
$42.5M
Q3 25
$-9.1M
$20.0M
Q2 25
$-10.1M
$18.0M
Q1 25
$-9.4M
$14.6M
Q4 24
$-10.0M
$34.5M
Q3 24
$-8.8M
$11.2M
Q2 24
$-10.6M
$18.2M
Q1 24
$-16.1M
$8.0M
FCF Margin
RPID
RPID
USCB
USCB
Q4 25
-29.6%
191.4%
Q3 25
-116.4%
80.3%
Q2 25
-138.6%
73.7%
Q1 25
-130.2%
63.9%
Q4 24
-121.8%
150.2%
Q3 24
-116.0%
52.2%
Q2 24
-159.8%
88.8%
Q1 24
-287.1%
45.4%
Capex Intensity
RPID
RPID
USCB
USCB
Q4 25
0.8%
1.4%
Q3 25
0.9%
0.5%
Q2 25
5.0%
0.2%
Q1 25
4.4%
0.2%
Q4 24
1.2%
1.4%
Q3 24
2.9%
0.4%
Q2 24
6.9%
0.4%
Q1 24
10.4%
0.5%
Cash Conversion
RPID
RPID
USCB
USCB
Q4 25
31.40×
Q3 25
2.25×
Q2 25
2.22×
Q1 25
1.91×
Q4 24
5.05×
Q3 24
1.63×
Q2 24
2.95×
Q1 24
1.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RPID
RPID

Products$9.3M83%
Services$2.0M17%

USCB
USCB

Segment breakdown not available.

Related Comparisons